Dipraglurant

N/A

Report date: 2025/10/04 20:00:12
NME

Base Information

Drug NameDipraglurant
Drug Alias NameADX-48621Dipraglurant-ERDipraglurant-MR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 modulators
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsBlepharospasmDystoniaDyskinesia, Drug-Induced +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustriaGermany +[4
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAddex Pharma Sa
Active IndicationsBlepharospasmDystonia
Inactive IndicationsDyskinesia, Drug-InducedDyskinesiasParkinson Disease

Other Information

ATC CodeN/A
Related LinksWikipedia